pharmaceuticals

Syndax’s Revumenib Added to NCCN AML Guidelines Ahead of October 25 FDA Decision

Syndax’s Revumenib Added to NCCN AML Guidelines Ahead of October 25 FDA Decision

admin October 4, 2025

Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the best stocks to buy under $20. On September 19,...

Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About

mccullough-speaking-flag

Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About

admin September 28, 2025

(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with...

Eli Lilly (LLY) Stock: Dips as $6.5B Bet on Obesity Pill Boosts U.S. Expansion Eli-Lilly-1-1200x800-1

Eli-Lilly-1-1200x800-1

Eli Lilly (LLY) Stock: Dips as $6.5B Bet on Obesity Pill Boosts U.S. Expansion

admin September 23, 2025

TLDR Eli Lilly invests $6. 5B in Houston plant to make obesity pill orforglipron. $6. 5B Houston...

Friendly links